Cross-border converter
NACE Rev 2.1 21.10 → TOL 2025 equivalent (Finland)
Cyprus's national activity classification (NACE Rev 2.1) shares its 4-digit backbone with the EU NACE Rev 2.1 standard. We use that backbone to surface the equivalent TOL 2025 subclass(es) used in Finland.
Shared EU parent
21.10
Manufacture of basic pharmaceutical products
This class includes: - manufacture of active pharmaceutical ingredients to be used for their pharmacological properties in the manufacture of medical products (e.g. antibiotics, basic vitamins, salicylic and O-acetylsalicylic acids) - processing of blood This class also includes: - manufacture of chemically pure sugars - manufacture of probiotics - processing of glands and manufacture of extracts of glands, etc. This class excludes: - manufacture of advance cell and gene therapy pharmaceutical preparations, see 21.20
21.10
Manufacture of basic pharmaceutical products
21100
Manufacture of basic pharmaceutical products
About this conversion
NACE Rev 2.1 is the activity classification used in Cyprus. TOL 2025 is the equivalent system in Finland. Both are national implementations of EU NACE Rev 2.1, so any 5th-digit subclass in one system can be traced back to a shared 4-digit EU class — and from there, forward into the other country's subclasses.
This page is generated for the query "NACE Rev 2.1 21.10 to TOL 2025" and stays in sync with our monthly Market Intelligence sync.